MapLight Therapeutics, Inc.
MPLT
Jodie situation report
MapLight Therapeutics, Inc.'s current read is isolated; its market group is not confirming.
No new filing conclusion is available. 0 of 8 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 1 directly disclosed connection is confirming.
- MPLT's market-adjusted activity becomes unusual and at least one connected name confirms.
Invalidation: The isolated read changes if MPLT's group or a disclosed connection begins moving with it.
Who this business touches
The relationships behind MPLT
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
ACADACADIA Pharmaceuticals Inc.competitorMar 26, 2026 ▾
“We may also face competition from other companies developing product candidates to address ADP that modulate other receptors, including ACP-204, which is being developed by Acadia Pharmaceuticals, Inc.”
Filing peers
No filing peers are available for this name yet.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
MPLT is currently a Leader in the organic co-movement group Healthcare Biotech & Midstream. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 1 filing-linked name are in the relationship map; none is currently confirmed as moving with the group.
This group is retained as the last observed read for MPLT; it is not active in the latest market snapshot.